Skip to main content
. 2021 Dec 15;26(24):7594. doi: 10.3390/molecules26247594

Table 1.

Susceptibility testing of S. aureus towards model compound 1 and newly synthesized analogues.

S. aureus ATCC29213
MHB-II TSB
Compounds Structure MIC
(µg/mL)		 MBC
(µg/mL)		 MIC
(µg/mL)		 MBC
(µg/mL)
1 graphic file with name molecules-26-07594-i001.jpg 2 * ≥512 ≥512 ≥512
10 graphic file with name molecules-26-07594-i002.jpg 4 * ≥512 32 * ≥512
15 graphic file with name molecules-26-07594-i003.jpg 16 * ≥512 32 * ≥512
27 graphic file with name molecules-26-07594-i004.jpg 16 * ≥512 16 * 16 *
32 graphic file with name molecules-26-07594-i005.jpg 2 * 8 2 * 2 *
33 graphic file with name molecules-26-07594-i006.jpg 4 * 4 4 * 4 *
35 graphic file with name molecules-26-07594-i007.jpg 256 ≥512 ≥512 ≥512
Tobramycin <0.5 <0.5 <0.5 <0.5

* The bacteria were able to grow at high concentrations of the tested compounds (see main text).